Nastja Kućišec
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nastja Kućišec has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Josip Bago
Division of Gastroenterology, Department of Internal Medicine, University Hospital Sveti Duh, Zagreb, Croatia
1 shared publication - Karolina Majstorović
Department of Gastroenterology, Internal Medicine Clinic, Clinical Hospital Sveti Duh, Zagreb, Croatia
1 shared publication - Monika Tomić
Department of Internal Medicine, University Clinical Hospital Mostar, Kralja Tvrtka bb, 88000 Mostar, Bosnia and Herzegovina
1 shared publication - Petra Bago Rožanković
Department of Neurology, University Hospital Dubrava, Avenija Gojka Šuška 6, 10000 Zagreb, Croatia
1 shared publication - Rosana Troskot
Department of Gastroenterology and Hepatology, University Hospital Sveti Duh, Sveti Duh 64, 10000 Zagreb, Croatia,
1 shared publication - Vinko Bakula
Department of Gastroenterology, Internal Medicine Clinic, Clinical Hospital Sveti Duh, Zagreb, Croatia
1 shared publication
Latest Publications
- Open Access
- 1 January 2010
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 9 (1) , 13
Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial
Antibiotic resistance decreases success of Helicobacter pylori (Hp) eradication. Recently published results show low rate of resistance and better compliance with moxifloxacin based regiments.
- 1 January 2010
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 9 (1) , 13
Open AccessAntimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial
Antibiotic resistance decreases success of Helicobacter pylori (Hp) eradication. Recently published results show low rate of resistance and better compliance with moxifloxacin based regiments.